Harborfront Financial Group LLC

Position in JNJ — Johnson & Johnson

CIK 2110061 LUDINGTON, MI

Position in JNJ

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$130,540

New position

Shares Held

514

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

1.09%

of 13F equity value

Holder Rank

#4,559

of 4,676 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Harborfront Financial Group LLC holds $636,529 across 6 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	294	$352,632
2	JNJ	Johnson & Johnson This page	514	$130,540
3	MRK	Merck & Co., Inc.	624	$80,184
4	ABBV	AbbVie Inc.	242	$60,896
5	PFE	Pfizer Inc	475	$11,438
6	OGN	Organon & Co.	62	$839

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$130,540	514	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.